Collaborations & Alliances

GenScript, Allozymes Partner to Advance Enzyme Discovery and Development

GenScript will provide the mutant libraries construction and expression and Allozymes will provide ultra-high-throughput screening.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

GenScript Biotech Corp., a provider of life-science research tools and services, is partnering with Allozymes, a Singapore-based biotech startup, to dramatically accelerate the enzyme discovery and development process. GenScript will provide the mutant libraries construction and expression and Allozymes will provide ultra-high-throughput screening service for applications across various industries, including pharmaceuticals, cosmetics, and food and beverage.   Naturally occurring enzymes and m...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters